Porcilis Ery+Parvo
An inactivated vaccine against erysipelas and parvovirus infection for use in pigs. This product may only be prescribed by your veterinary practitioner from whom advice must be sought.
Product Information for Veterinary Healthcare Professionals
Porcilis Ery+Parvo is an inactivated vaccine containing at least 1 ppd Erysipelothrix rhusiopathiae antigen, strain M2 (serotype 2) and Porcine parvovirus (PPV) strain 014 ≥ 552 EU per dose (as determined in the final product antigenic mass ELISA) in an aqueous adjuvant. The vaccine contains 150 mg dl-α tocopherol per dose.
The product is for the active immunisation of sows and gilts as an aid in the control of swine erysipelas and for the protection of embryos and foetuses against porcine parvovirus infection.
Further information is available on request. Use medicines responsibly.
Legal category
POM-V
Packaging Quantities
Multidose vials containing 10, 25, 50 or 125 doses.
Summary of Product Characteristics
For Summary of Product Characteristics, first click on this link. Then type in Porcilis Ery+Parvo in Product name field. Click on Run search. Subsequently click on View SPC on line listing opposite Porcilis Ery+Parvo.